Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc |
Journal website https://www.jofem.org |
Original Article
Volume 13, Number 2, June 2023, pages 49-56
Efficacy of I-131 Treatment Dosage for Hyperthyroidism With Current Institution Formula
Tables
Age (mean ± SD) | 48.7753 ± 13.26286 |
---|---|
SD: standard deviation. | |
Gender, n % | |
Females | 74 (83.1%) |
Males | 15 (16.9%) |
Ethnicity, % | |
Chinese | 1.1% |
Declined | 2.2% |
Ecuadorian | 1.1% |
Filipino | 2.2% |
Guatemalan | 1.1% |
Mexican/Mexican American | 4.5% |
Non-Hispanic | 52.8% |
Other Hispanic | 1.1% |
Salvadoran | 2.2% |
Unknown | 31.5% |
Preliminary diagnosis, % | |
Graves with thyrotoxicosis | 1.1% |
Graves’ disease | 67.4% |
Hyperthyroidism | 2.2% |
Multinodular goiter | 3.4% |
Multinodular goiter or thyroid adenoma | 1.1% |
Questionable toxic thyroid nodule | 1.1% |
Subclinical hyperthyroidism | 1.1% |
Thyrotoxicosis | 2.2% |
Toxic multinodular goitre | 10.1% |
Toxic thyroid nodule | 10.1% |
Thyroid uptake percentage (mean ± SD) | 62.03 ± 23.89 |
Dosage (I-131) in mCi | N | % |
---|---|---|
10.60 | 1 | 1.1% |
15.00 | 2 | 2.2% |
20.00 | 1 | 1.1% |
25.00 | 1 | 1.1% |
30.00 | 1 | 1.1% |
31.00 | 1 | 1.1% |
39.70 | 1 | 1.1% |